Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.
Keywords: COVID‐19 infection; Nepal; convalescent plasma therapy; multimorbidity.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.